Patent Assignment
Reel/Frame 061447/0760
Assignment of Assignor's Interest
Recorded: 2022-09-15
Pages: 47
Assignor
SHIRE HUMAN GENETIC THERAPIES, INC.
Executed: 2022-07-11
Assignee
TAKEDA PHARMACEUTICAL COMPANY LIMITED
1-1, DOSHOMACHI 4-CHOME, CHUO-KU, OSAKA-SHI, 541-0045, JAPAN
Covered Properties
(42)
Diagnosis and Treatment of Multiple Sulfatase Deficiency and Other Sulfatase Deficiencies
PCT:
PCT/US2004/003632 ↗
Methods and Compositions for Cns Delivery of Heparan N-Sulfatase
PCT:
PCT/US2011/041922 ↗
Cns Delivery of Therapeutic Agents
PCT:
PCT/US2011/041924 ↗
Methods and Compositions for Cns Delivery of Iduronate-2-Sulfatase
PCT:
PCT/US2011/041925 ↗
Methods and Compositions for Cns Delivery of Arylsulfatase A
PCT:
PCT/US2011/041926 ↗
Treatment of Sanfilippo Syndrome Type B
PCT:
PCT/US2011/041928 ↗
Process for Purifying Heparan-N-Sulfatase
PCT:
PCT/US2012/038630 ↗
Biomarkers for Sanfilippo Syndrome and Uses Thereof
PCT:
PCT/US2012/063935 ↗
Stable Formulations for Cns Delivery of Arylsulfatase A
PCT:
PCT/US2012/071473 ↗
Treatment of Cognitive Impairment of Hunter Syndrome by Intrathecal Delivery of Iduronate-2-Sulfatase
PCT:
PCT/US2012/071495 ↗
Purification of Iduronate-2-Sulfatase
PCT:
PCT/US2013/048561 ↗
Cells for Producing Recombinant Iduronate-2-Sulfatase
PCT:
PCT/US2013/048571 ↗
Methods and Compositions for Intrathecally Administered Treatment of Mucupolysaccharidosis Type Iiia
PCT:
PCT/US2013/073677 ↗
Method of Characterizing Lysosomal Enzymes
PCT:
PCT/US2014/026673 ↗
A Cell That Expresses a Sulfatase and a Formylglycine Generating Enzyme
Methods and Compositions for Cns Delivery of Heparan N-Sulfatase
Cns Delivery of Therapeutic Agents
Methods and Compositions for Cns Delivery of Arylsulfatase A
Methods and Compositions for Cns Delivery of Iduronate-2-Sulfatase
Purification of Iduronate-2-Sulfatase
Cells for Producing Recombinant Iduronate-2-Sulfatase
Treatment of Sanfilippo Syndrome Type B by Intrathecal Administration of Alpha-N-Acetylglucosaminidase
Methods and Compositions for Cns Delivery of Iduronate-2-Sulfatase
Method of Analyzing the Charge Profile of Heparan N-Sulfatase
Methods and Compositions for Treatment of Hunter Syndrome
Cells for Producing Recombinant Iduronate-2-Sulfatase
Cns Delivery of Therapeutic Agents
Characterization of Lysosomal Enzymes by Capillary Zone Electrophoresis
Methods and Compositions for Treatment of Hunter Syndrome
Methods and Compositions for Cns Delivery of Arylsulfatase A
Therapeutic Fusion Protein Comprising an Alpha-N-Acetylglucosaminidase and a Lysosomal Targeting Moiety
Treatment of Cognitive Impairment of Mucopolysaccharidosis Type IIIA by Intrathecal Delivery of Heparan N-Sulfatase
Stable Formulations for Cns Delivery of Arylsulfatase A
Methods and Compositions for Cns Delivery of Heparan N-Sulfatase
Methods and Compositions for Cns Delivery of Iduronate-2-Sulfatase
Cns Delivery of Therapeutic Agents
Methods and Compositions for CNS Delivery of Arylsulfatase A
Stable Formulations for Cns Delivery of Arylsulfatase A
Application:
16/851,822 →
Publication:
US 2020/0237883
Compositions Comprising Iduronate-2-Sulfatase
Methods and Compositions for Cns Delivery of Heparan N-Sulfatase
Treatment of Sanfilippo Syndrome Type B
Application:
17/350,909 →
Publication:
US 2022/0133863
Methods and Compositions for Cns Delivery of Iduronate-2-Sulfatase
Related Assignments
(17)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 30, 2006
From: VON FIGURA, KURT; SCHMIDT, BERNHARD; DIERKS, THOMAS; HEARTLEIN, MICHAL W.
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 018583/0228 →
Assignment of Assignor's Interest
Aug 30, 2011
From: ZHU, GAOZHONG; LOWE, KRIS; SHAHROKH, ZAHRA; CHRISTIAN, JAMES
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 026825/0422 →
Assignment of Assignor's Interest
Aug 30, 2011
From: SALAMAT-MILLER, NAZILA; TAYLOR, KATHERINE; CAMPOLIETO, PAUL; SHAHROKH, ZAHRA
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 026825/0460 →
Assignment of Assignor's Interest
Sep 22, 2011
From: NATOLI, FARAH; ZHU, GAOZHONG; TEREW, JENNIFER; JIANG, YUAN
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 026949/0809 →
Assignment of Assignor's Interest
Sep 22, 2011
From: CALIAS, PERICLES; PAN, JING; POWELL, JAN; CHARNAS, LAWRENCE
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 026949/0964 →
Assignment of Assignor's Interest
Sep 22, 2011
From: CONCINO, MICHAEL F.; CALIAS, PERICLES; PAN, JING; HOLMES, KEVIN
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 026949/0870 →
Assignment of Assignor's Interest
Aug 31, 2012
From: NICHOLS, DAVID
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 028881/0303 →
Assignment of Assignor's Interest
Jan 28, 2013
From: HASLETT, PATRICK; RICHARD, CHARLES W., III
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 029701/0793 →
Assignment of Assignor's Interest
Mar 8, 2013
From: BARBIER, ANN; MCCAULEY, THOMAS; RICHARD, III, CHARLES W.
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 029948/0947 →
Assignment of Assignor's Interest
Apr 16, 2013
From: NICHOLS, DAVE
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 030223/0038 →
Assignment of Assignor's Interest
Apr 16, 2013
From: BOLDOG, FERENC; HEARTLEIN, MICHAEL
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 030223/0133 →
Assignment of Assignor's Interest
Jul 26, 2013
From: CONCINO, MICHAEL F.; CALIAS, PERICLES; PAN, JING; HOLMES, KEVIN
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 030882/0744 →
Assignment of Assignor's Interest
Nov 25, 2013
From: ZHU, GAOZHONG; LOWE, KRIS; SHAHROKH, ZAHRA; CHRISTIAN, JAMES
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 031666/0107 →
Assignment of Assignor's Interest
Apr 15, 2014
From: HASLETT, PATRICK; BARBIER, ANN; CALIAS, PERICLES; PFEIFER, RICHARD
To: SHIRE HUMAN GENETIC THERAPIES, INC
Reel/Frame 032681/0167 →
Assignment of Assignor's Interest
Aug 7, 2014
From: ROSEMAN, DANIEL S.
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 033487/0575 →
Assignment of Assignor's Interest
Apr 7, 2015
From: NICHOLS, DAVE
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 035347/0147 →
Assignment of Assignor's Interest
Sep 1, 2015
From: BOLDOG, FERENC; HEARTLEIN, MICHAEL
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 036465/0257 →